Pharmacologie Flashcards
Quelles sont les classes d’anti-arrythmiques ?
Class I : Sodium channel blockers
Class II : Beta-blockers
Class III : Potassium channel blockers
Class IV : Calcium channel blockers
Class V : Others
MOA Diltiazem
Class IV : Calcium channel blockers
MOA Sotalol
Class II : Beta-blocker surtout
Potassium channel blockers (arythmies supraV et ventriculaires car joue sur la repolarisation des cellules)
MOA mexilitine
Class Ib : Sodium channel blockers
MOA Atenolol
Class II: Beta-blocker –>Sélectif B1(minimal B2 effet at high doses)
MOA lidocaine
Class Ib : Sodium channel blockers
MOA Digoxin
Class V : Na+/K+ ATPase
MOA Procainamide
Classe Ia : Sodium channel blockers
Potassium channel blocker
MOA Propafenone
Class Ic : Sodium channel blockers
Potassium channel blocker
MOA Amiodarone
Class III : Potassium channel blockers
Beta-blocker
Sodium channel blockers
Calcium channel blockers
Lieu d’action sur le rein des diurétiques : Furosemide
Loop of Henle : Inihibiteur deu co-transporteur Na+/K+/2Cl- ATPase
Lieu d’action sur le rein des diurétiques : Spironolactone
Inhibiteur des récepteurs à l’aldostérone et Potassium sparing diuretic
Tubules contournés distaux ou tubule collecteur selon les sources
Lieu d’action sur le rein des diurétiques : Hydrochlorothiazide
Tubules collecteurs
Bloque les transporteurs Na+/Cl-
MOA Atenolol
Beta-blocker (B1 selective). À haute dose peut être légèrement B2
Inotrope -, chronotrope -
(Diminue sinus HR & AV conduction + Diminue O2 myocardial consumption)
MOA Clopidogrel
Binds to platelet surface ADP ( P2Y12) & irreversibly alters receptor for the lifespan of the platelet
MOA Rivaroxaban
Inhibitor of activated clotting factor Xa & prothrombinase activity
MOA Heparin
Binds to anti-thrombin & change conformation which accelerates the binding of anti-thrombin to activated clotting factor (Xa, IIa ++) to inactivate their procoagulation activity
Inhibits factor XIII
MOA TPA
Tissue plasminogen activator : thrombolysis
MOA Warfarin
Inhibits Vitamin K epoxidase reductase (VKOR1) which interferes with Vit K action in synthesis of clotting factors (II, VII,IX, X)
Anticoagulant of protein C & S
MOA Pimobendane
Inhibitor of PDE III by increasing intracellular Ca2+ sensitivity in cardiac contractile apparatus. it increases AMPc in the cells.
MOA Sildenafil
Inhibition of cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type V found in smooth muscle of pulmonary vasculature (Increased GMPc)
MOA Benazepril
Inhibitor of angiotensin converting enzyme (inhibits conversion of Ang I to II
MOA Amlodipine
Dihydropyridine L-type calcium channel blocker that inhibits voltage gated Ca2+ channel in heart & vasculature smooth muscles
L-type calcium channel also found in afferent arteriole in kidney
MOA Telmisartan
Selective blockage of AT1 receptor & aldosterone synthesis/secretion
leading to vasodilation & increased Na+ excretion